Defective yeast opsonisation and functional deficiency of complement in sickle cell disease
- PMID: 7092289
- PMCID: PMC1627548
- DOI: 10.1136/adc.57.5.343
Defective yeast opsonisation and functional deficiency of complement in sickle cell disease
Abstract
Opsonisation of heat-killed baker's yeast, functional activity of the total alternative pathway of complement, and factor B detected functionally and immunochemically were significantly reduced in 72 children with sickle cell disease compared with 40 age-matched black control children. There was significant correlation between functional activity of the total alternative pathway and functionally measured factor B, but not between factor B measured functionally and immunochemically. The opsonisation defect could be corrected in vitro by normal serum, and factor B-depleted serum, and was qualitatively similar to that seen in patients with primary yeast opsonisation deficiency. Serial studies showed that these serum defects were persistent. Reduction in the activity of components of the alternative pathway of complement and opsonisation was found in 4 patients who had recovered from pneumococcal meningitis and in one who developed osteomyelitis. Defects of yeast opsonisation and complement which are common in patients with sickle cell disease, may partly explain the children's increased susceptibility to infection, and might help to identify individuals especially at risk.
Similar articles
-
Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure.Gut. 1980 Aug;21(8):643-9. doi: 10.1136/gut.21.8.643. Gut. 1980. PMID: 7000632 Free PMC article.
-
Bacterial and fungal infection in children with fulminant hepatic failure: possible role of opsonisation and complement deficiency.Gut. 1982 Dec;23(12):1037-43. doi: 10.1136/gut.23.12.1037. Gut. 1982. PMID: 6757064 Free PMC article.
-
Yeast opsonisation and complement in children with liver disease. Analysis of 69 cases.Pediatr Res. 1983 Apr;17(4):296-300. doi: 10.1203/00006450-198304000-00014. Pediatr Res. 1983. PMID: 6343990
-
[Infection and immunity in sickle cell disease].AMB Rev Assoc Med Bras. 1989 Mar-Apr;35(2):70-4. AMB Rev Assoc Med Bras. 1989. PMID: 2695986 Review. Portuguese.
-
Complement and the host's defense against the pneumococcus.Crit Rev Microbiol. 1984;11(3):187-208. doi: 10.3109/10408418409105903. Crit Rev Microbiol. 1984. PMID: 6391822 Review.
Cited by
-
Complement in Sickle Cell Disease: Are We Ready for Prime Time?J Blood Med. 2021 Mar 23;12:177-187. doi: 10.2147/JBM.S287301. eCollection 2021. J Blood Med. 2021. PMID: 33790681 Free PMC article. Review.
-
Sickle Cell Disease and Infections in High- and Low-Income Countries.Mediterr J Hematol Infect Dis. 2019 Jul 1;11(1):e2019042. doi: 10.4084/MJHID.2019.042. eCollection 2019. Mediterr J Hematol Infect Dis. 2019. PMID: 31308918 Free PMC article. Review.
-
Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.Clin Diagn Lab Immunol. 2000 Sep;7(5):788-93. doi: 10.1128/CDLI.7.5.788-793.2000. Clin Diagn Lab Immunol. 2000. PMID: 10973456 Free PMC article.
-
Sepsis caused by Mycobacterium terrae complex in a patient with sickle cell disease.BMJ Case Rep. 2013 May 2;2013:bcr2013009159. doi: 10.1136/bcr-2013-009159. BMJ Case Rep. 2013. PMID: 23645646 Free PMC article.
-
Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019.Pediatrics. 2022 Jan 1;149(1):e2021051892. doi: 10.1542/peds.2021-051892. Pediatrics. 2022. PMID: 34913059 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical